Clinical trial
Optimal Antitachycardia Therapy in ICD Patients Without Pacing Indications
NCT00729703 is registered in ClinicalTrials.gov with LivaNova as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimal Antitachycardia Therapy in ICD Patients Without Pacing Indications
- Lead sponsor
- LivaNova
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2006
- Completion date
- October 31, 2013
- Enrollment
- 462 (actual)
- Sites
- 55
Conditions
As the registry lists them; a condition with its own page is linked.